Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation [10]

Nephrology Dialysis Transplantation

Volumn 22, Issue 8, 2007, Pages 2412-2414

  Korte, Mario R ^a   Yo, Marieke ^b   Betjes, Michiel G H ^a   Fieren, Marien W ^a   van Saase, Jan C L M ^a   Boer, Walther H ^b   Weimar, Willem ^a   Zietse, Robert ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ICODEXTRIN;

ADULT; CONTROLLED STUDY; DISEASE SEVERITY; EPIDEMIC; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; LETTER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; NETHERLANDS; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONITIS; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; UNIVERSITY HOSPITAL;

ADULT; FEMALE; GLUCANS; GLUCOSE; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; PREVALENCE; SCLEROSIS; TIME FACTORS;

EID: 34547830292     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm171     Document Type: Letter

References (15)

1. Gandhi VC, Humayun HM, Ing TS et al. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 1980; 140: 1201-1203
2. Rigby RJ, Hawley CM. Sclerosing peritonitis: The experience in Australia. Nephrol Dial Transplant 1998; 13: 154-159
3. Kawanishi H, Kawaguchi Y, Fukui H et al. Encapsulating peritoneal sclerosis in Japan: A prospective, controlled, multi-center study. Am J Kidney Dis 2004; 44: 729-737
4. Summers AM, Clancy MJ, Syed F et al. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int 2005; 68: 2381-2388
5. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: Definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20 [Suppl 4]: S43-S55
6. Goffin E. Aseptic peritonitis and icodextrin. Perit Dial Int 2006; 26: 314-316
7. Nomoto Y, Kawaguchi Y, Kubo H et al. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: A report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis 1996; 28: 420-427
8. Saito A. Peritoneal dialysis in Japan: The issue of encapsulating peritoneal sclerosis and future challenges. Perit Dial Int 2005; 25 [Suppl 4]: S77-S82
9. Zweers MM, Douma CE, de Waart DR et al. The standard peritoneal permeability analysis in the rabbit: A longitudinal model for peritoneal dialysis. Perit Dial Int 1999; 19: 56-64
10. De Vriese AS, Flyvbjerg A, Mortier S, Tilton RG, Lameire NH. Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane. J Am Soc Nephrol 2003; 14: 2109-2118
11. Schwenger V. GDP and AGE receptors: Mechanisms of peritoneal damage. Contrib Nephrol 2006; 150: 77-83
12. Boer WH, Vos PF, Fieren MW. Culture-negative peritonitis associated with the use of icodextrin-containing dialysate in twelve patients treated with peritoneal dialysis. Perit Dial Int 2003; 23: 33-38
13. MacGinley R, Cooney K, Alexander G, Cohen S, Goldsmith DJ. Relapsing culture-negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution. Am J Kidney Dis 2002; 40: 1030-1035
14. Maluccio M, Sharma V, Lagman M et al. Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. Transplantation 2003; 76: 597-602
15. Khanna A, Plummer M, Bromberek C, Bresnahan B, Hariharan S. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. Kidney Int 2002; 62: 2257-2263